Scheme

SBI Healthcare Opportunities Fund

Holds 35 companies worth ₹5,608 Cr in Sept 2026.

Fund house
SBIThe fund house that runs this scheme.
AUM
₹5,870 CrSBI Healthcare Opportunities Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 1.3% on Aug 2026, ₹5,796 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 11.1% of this scheme's NAV.
Fund manager
Tanmaya DesaiRuns it since 27 Jun 2011, as the fund house dates it.

Holdings^{(Jul 2018 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	35 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	654
	Divi s Laboratories Limited	465
	Acutaas Chemicals Limited	295
	Apollo Hospitals Enterprise Limited	261
	Torrent Pharmaceuticals Limited	259
	Cipla	258
	Laurus Labs Limited	238
	Max Healthcare Institute Limited	223
	Aurobindo Pharma	201
	Aster DM Healthcare Limited	188
	Gland Pharma Limited	174
	Sudeep Pharma Limited	164
	Anthem Biosciences Limited	161
	Sai Life Sciences Limited	152
	Corona Remedies Limited	142
	Biocon	139
	Fortis Healthcare Limited	139
	Concord Biotech Limited	132
	Aether Industries Limited	127
	Jupiter Life Line Hospitals Limited	127
	Poly Medicure Limited	107
	Ajanta Pharmaceuticals Limited	105
	Global Health Limited	102
	Mankind Pharma Limited	100
	Healthcare Global Enterprises Limited	99.9
	Krishna Institute of Medical Science Ltd	99.4
	Cohance Lifesciences Limited	97.7
	Innova Captab Limited	96.6
	Dr Lal Path Labs Limited	95.4
	Nephrocare Health Services Ltd	66
	Syngene International Limited	65.8
	Rainbow Children s Medicare Limited	39.4
	Gufic Biosciences Limited	17.3
	Abbott India Limited	13.6
	Novartis India Ltd	2.3

Sun Pharmaceutical Ind Ltd
Divi s Laboratories Limited

Market value of each ticked company in SBI Healthcare Opportunities Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Divi s Laboratories Limited
Sept 2025	₹430 Cr	₹250 Cr
Oct 2025	₹456 Cr	₹296 Cr
Nov 2025	₹495 Cr	₹285 Cr
Dec 2025	₹464 Cr	₹281 Cr
Jan 2026	₹383 Cr	₹266 Cr
Feb 2026	₹434 Cr	₹308 Cr
Mar 2026	₹492 Cr	₹268 Cr
Apr 2026	₹506 Cr	₹293 Cr
May 2026	₹504 Cr	₹300 Cr
Jun 2026	₹559 Cr	₹296 Cr
Jul 2026	₹687 Cr	₹403 Cr
Aug 2026	₹715 Cr	₹473 Cr
Sept 2026	₹654 Cr	₹465 Cr

Fig. 1.Market value of each ticked company in SBI Healthcare Opportunities Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	5	32.32

Mid Cap	10	25.69

Small Cap	20	37.51

Cash & others		4.48

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	36L	654	11.14
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	5L	465	7.91
Acutaas Chemicals Limited	Equity	Pharmaceuticals & Biotechnology	9L	295	5.03
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	3.2L	261	4.45
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	5.4L	259	4.42
Cipla	Equity	Pharmaceuticals & Biotechnology	19.2L	258	4.40
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	12L	238	4.05
Max Healthcare Institute Limited	Equity	Healthcare Services	24L	223	3.80
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	12L	201	3.42
Aster DM Healthcare Limited	Equity	Healthcare Services	27L	188	3.21
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	6L	174	2.96
Sudeep Pharma Limited	Equity	Pharmaceuticals & Biotechnology	13.6L	164	2.79
Anthem Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	18.8L	161	2.75
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	10L	152	2.60
Corona Remedies Limited	Equity	Pharmaceuticals & Biotechnology	6.8L	142	2.43
Biocon	Equity	Pharmaceuticals & Biotechnology	37.5L	139	2.37
Fortis Healthcare Limited	Equity	Healthcare Services	18L	139	2.36
Concord Biotech Limited	Equity	Pharmaceuticals & Biotechnology	9.6L	132	2.25
Aether Industries Limited	Equity	Chemicals & Petrochemicals	7.5L	127	2.17
Jupiter Life Line Hospitals Limited	Equity	Healthcare Services	50L	127	2.16
Poly Medicure Limited	Equity	Healthcare Equipment & Supplies	6.4L	107	1.82
Ajanta Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	2.9L	105	1.79
Global Health Limited	Equity	Healthcare Services	7.5L	102	1.74
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	4L	100	1.71
Healthcare Global Enterprises Limited	Equity	Healthcare Services	15L	99.9	1.70
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	13.3L	99.4	1.69
Cohance Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	22L	97.7	1.66
Innova Captab Limited	Equity	Pharmaceuticals & Biotechnology	8.33L	96.6	1.65
Dr Lal Path Labs Limited	Equity	Healthcare Services	4.8L	95.4	1.62
Nephrocare Health Services Ltd	Equity	Healthcare Services	10L	66	1.12
Syngene International Limited	Equity	Healthcare Services	18L	65.8	1.12
Rainbow Children s Medicare Limited	Equity	Healthcare Services	3L	39.4	0.67
Gufic Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	4L	17.3	0.29
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	5K	13.6	0.23
Novartis India Ltd	Equity	Pharmaceuticals & Biotechnology	12.2K	2.3	0.040

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.